-
EP2379066
European procedure
Extract from the Register of European Patents
EP About this file: EP2379066
| EP2379066 - USE OF OPIOID ANTAGONISTS FOR THE PREPARATION OF A MEDICAMENT IN THE TREATMENT OF RETINAL DEGENERATIVE DISEASES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 30.01.2015 Database last updated on 09.04.2026 | Most recent event Tooltip | 14.06.2019 | Change - lapse in a contracting state | published on 17.07.2019 [2019/29] | Applicant(s) | For all designated states Imuneks Farma Ilaç Sanayi Ve Ticaret A.S. Pak is Merkezi Prof. Dr. Bülent Tarcan Sok. No: 5/1 Gayrettepe 34349 Istanbul / TR | [2014/13] |
| Former [2014/03] | For all designated states Imunek Farma Ilaç Sanayi Ve Ticaret A.S. Pak is Merkezi Prof. Dr. Bülent Tarcan Sok. No: 5/1 Gayrettepe 34349 Istanbul / TR | ||
| Former [2011/43] | For all designated states Ak Kimya Ithalat-ihracat Ve Sanayii Anonim Sirketi Prof. Dr. Bülent Tarcan Sokak No.5 34349 Gayrettepe Istanbul / TR | Inventor(s) | 01 /
PISAK, Ibrahim Mustafa Iskender Park Is Merkezi Prof. Dr. Bulent Tarcan Sok. No: 5/1 Gayrettepe ISTANBUL 34349 / TR | 02 /
SELAMOGLU, Mehmet Levent Pak Is Merkezi Prof. Dr. Bulent Tarcan Sok. No: 5/1 Gayrettepe ISTANBUL 34349 / TR | 03 /
PAK, Nevhiz Pak Is Merkezi Prof. Dr. Bulent Tarcan Sok. No: 5/1 Gayrettepe ISTANBUL 34349 / TR | 04 /
BINGOL, Semra Pak Is Merkezi Prof. Dr. Bulent Tarcan Sok. No: 5/1 Gayrettepe ISTANBUL 34349 / TR | [2011/43] | Representative(s) | Kodron, Felix Rechtsanwalt Postfach 2649 55016 Mainz / DE | [2011/43] | Application number, filing date | 08807092.5 | 16.09.2008 | WO2008IB02412 | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010032073 | Date: | 25.03.2010 | Language: | EN | [2010/12] | Type: | A1 Application with search report | No.: | EP2379066 | Date: | 26.10.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.03.2010 takes the place of the publication of the European patent application. | [2011/43] | Type: | B1 Patent specification | No.: | EP2379066 | Date: | 26.03.2014 | Language: | EN | [2014/13] | Search report(s) | International search report - published on: | EP | 25.03.2010 | Classification | IPC: | A61K31/485, A61P27/02 | [2013/02] | CPC: |
A61K31/00 (EP,US);
A61K31/485 (EP,US);
A61K9/0048 (EP,US);
A61P27/00 (EP);
A61P27/02 (EP)
|
| Former IPC [2011/43] | A61K31/00, A61K31/485, A61P27/02 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2014/13] | Extension states | AL | Not yet paid | BA | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | VERWENDUNG VON OPIOID ANTGONISTEN ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON DEGENERATIVEN NETZHAUTERKRANKUNGEN | [2013/02] | English: | USE OF OPIOID ANTAGONISTS FOR THE PREPARATION OF A MEDICAMENT IN THE TREATMENT OF RETINAL DEGENERATIVE DISEASES | [2011/43] | French: | UTILISATION D'ANTAGONISTES DES OPIACÉS POUR LA PRÉPARATION D'UN MÉDICAMENT DANS LE TRAITEMENT DE MALADIES DÉGÉNÉRATIVES DE LA RÉTINE | [2014/04] |
| Former [2011/43] | VERWENDUNG VON OPIOID-ANTAGONISTEN ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG VON DEGENERATIVEN NETZHAUTERKRANKUNGEN | ||
| Former [2011/43] | UTILISATION D ANTAGONISTES DES OPIACÉS POUR LA PRÉPARATION D UN MÉDICAMENT DANS LE TRAITEMENT DE MALADIES DÉGÉNÉRATIVES DE LA RÉTINE | Entry into regional phase | 30.05.2011 | National basic fee paid | 30.05.2011 | Designation fee(s) paid | 30.05.2011 | Examination fee paid | Examination procedure | 30.05.2011 | Examination requested [2011/43] | 13.12.2011 | Amendment by applicant (claims and/or description) | 09.05.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time | 31.01.2013 | Communication of intention to grant the patent | 10.04.2013 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 26.04.2013 | Fee for grant paid | 26.04.2013 | Fee for publishing/printing paid | 02.01.2014 | Communication of intention to grant the patent | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 31.01.2013 | Opposition(s) | 06.01.2015 | No opposition filed within time limit [2015/10] | Request for further processing for: | The application is deemed to be withdrawn due to non-payment of the filing fee | 30.05.2011 | Request for further processing filed | 30.05.2011 | Full payment received (date of receipt of payment) Request granted | 14.06.2011 | Decision despatched | The application is deemed to be withdrawn due to non-payment of the examination fee | 30.05.2011 | Request for further processing filed | 30.05.2011 | Full payment received (date of receipt of payment) Request granted | 14.06.2011 | Decision despatched | The application is deemed to be withdrawn due to non-payment of designation fees TR, SK, SI, SE, RO, PT, PL, NO, NL, MT, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT | 30.05.2011 | Request for further processing filed | 30.05.2011 | Full payment received (date of receipt of payment) Request granted | 14.06.2011 | Decision despatched | Fees paid | Renewal fee | 08.08.2011 | Renewal fee patent year 03 | 14.05.2012 | Renewal fee patent year 04 | 13.09.2012 | Renewal fee patent year 05 | 20.08.2013 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 16.04.2011 | 03 M06 Fee paid on 08.08.2011 | 30.09.2011 | 04 M06 Fee paid on 14.05.2012 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2016/33] | TR | 26.03.2014 | Cited in | International search | [X] NI YING-QIN ET AL: "Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation", IOVS, vol. 49, no. 6, June 2008 (2008-06-01), pages 2589 - 2598, XP002550374, ISSN: 0146-0404 [X] 1,3 * page 2594, column R - page 2597, column L * DOI: http://dx.doi.org/10.1167/iovs.07-1173 | [A] LAM TIM T ET AL: "The effects of naloxone on retinal ischemia in rats", JOURNAL OF OCULAR PHARMACOLOGY, MARY ANN LIEBERT, INC. NEW YORK, NY, US, vol. 10, no. 2, 1 January 1994 (1994-01-01), pages 481 - 492, XP009124102, ISSN: 8756-3320 [A] 1-12 * abstract * DOI: http://dx.doi.org/10.1089/jop.1994.10.481 | [A] ZAGON ET AL: "Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium", BRAIN RESEARCH BULLETIN, ELSEVIER SCIENCE LTD, OXFORD, GB, vol. 72, no. 1, 13 February 2007 (2007-02-13), pages 18 - 24, XP005885659, ISSN: 0361-9230 [A] 1-12 * abstract * DOI: http://dx.doi.org/10.1016/j.brainresbull.2006.12.007 | [A] FISCHER A J ET AL: "OPIATE AND N-METHYL-D-ASPARTATE RECEPTORS IN FORM-DEPRIVATION MYOPIA", VISUAL NEUROSCIENCE, CAMBRIDGE UNIVERSITY PRESS, GB, vol. 15, no. 6, 1 November 1998 (1998-11-01), pages 1089 - 1096, XP009024602, ISSN: 0952-5238 [A] 1-12 * page 1092 * DOI: http://dx.doi.org/10.1017/S0952523898156080 | [A] GUPTA KALPNA ET AL: "Morphine exaggerates retinopathy in transgenic sickle mice.", BLOOD, vol. 106, no. 11, Part 1, November 2005 (2005-11-01), & 47TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ATLANTA, GA, USA; DECEMBER 10 -13, 2005, pages 64A - 65A, XP002550375, ISSN: 0006-4971 [A] 1-12 * abstract * | [A] COOK H L ET AL: "Age-related macular degeneration: diagnosis and management", BRITISH MEDICAL BULLETIN, vol. 85, March 2008 (2008-03-01), pages 127 - 149, XP002550376, ISSN: 0007-1420 [A] 1-12 * table 1 * DOI: http://dx.doi.org/10.1093/bmb/ldn012 | [A] DELYFER MARIE-NOELLE ET AL: "Inherited retinal degenerations: therapeutic prospects", BIOLOGY OF THE CELL (PARIS), vol. 96, no. 4, May 2004 (2004-05-01), pages 261 - 269, XP002550377, ISSN: 0248-4900 [A] 1-12 * page 263, column L - page 265 * DOI: http://dx.doi.org/10.1016/J.BIOLCEL.2004.01.006 |